尿调蛋白抑制补体活化在糖尿病肾病中的保护作用研究
批准号:
82070749
项目类别:
面上项目
资助金额:
55.0 万元
负责人:
陈育青
依托单位:
学科分类:
继发性肾脏疾病
结题年份:
2024
批准年份:
2020
项目状态:
已结题
项目参与者:
陈育青
中文摘要
肾小管损伤在糖尿病肾病(DKD)发病及进展中起重要作用。补体过度活化诱发下游炎症是DKD进展的重要机制。肾小管髓袢升支粗段到远曲小管是重要调节区,尿调蛋白(UMOD)表达于该部位上皮细胞,分泌到尿和血中,是肾脏的保护因子。UMOD可通过和补体成分相互作用,抑制补体过度活化,加速补体降解。我们假设UMOD通过调节补体活化,降低补体活化后的炎症状态,对糖尿病肾病发生和进展有保护作用。我们使用UMOD基因敲除SD大鼠,建立1型DKD模型,通过血/尿的生化指标,肾组织病理和生物标志物变化,探讨UMOD是否在DKD的发生进展中起保护作用。通过转录组学,蛋白质表达及组织学水平的研究,探讨尿调蛋白对补体的调节在疾病模型的状态下作用的机制。体外高糖培养UMOD基因敲除和野生型的大鼠的肾小管上皮细胞及肾小管细胞系,利用重组人源性UMOD片段,初步探讨外源性UMOD片段作为治疗手段的可能性。
英文摘要
The abnormality of natural immunity is one of the pathogenic mechanisms of diabetic kidney disease (DKD). The local over activation caused by the abnormal regulation of complement is an important factor to induce the downstream inflammation. Renal tubular injury plays an important role in the incidence and progression of DKD. The ascending branch of the medullary loop and the beginning of the distal convoluted tubules are important areas of the renal autonomic regulation. Uromodulin (UMOD) is expressed specifically in the same area and plays a protective role in renal tubular injury. Uromodulin can inhibit over activation of complements and accelerate the degradation of C3b. Some studies have also suggested that UMOD changed in early stage of diabetic nephropathy and related to the severity of diabetes mellitus. We proposed that uromodulin can inhibit the over activation of complements in the kidney, reduce the inflammation and protect the occurrence and progress of diabetic nephropathy. In this study, we will set up diabetic nephropathy model in UMOD gene knockout SD rats to explore the protective effect of uromodulin in early diabetic nephropathy and the role of uromodulin-complement interaction in diabetic nephropathy. The main contents of this study include: 1) using diabetic nephropathy UMOD-/- SD rats to explore the role of UMOD in occurrence and progression of diabetic nephropathy, by biochemical indicators of plasma and urine and renal histopathology. 2) using animal model to study the regulatory effect of uromodulin on complement pathway on the occurrence and progress of diabetic nephropathy. The blood, urine and kidney tissue were collected at different time points after diabetes mellitus modeling. The activation of complement pathway and the activation of inflammatory factors downstream were detected by immunofluorescence, ELISA, RT-PCR and western blot and protein chip. 3) The renal tubular epithelial cells of umod knockout and wild-type SD rats were cultured in vitro with high glucose to observe complement activation and subsequent inflammatory response. The aim of this study was to explore the possibility of exogenous UMOD fragments as a therapeutic regent.
本研究聚焦尿调蛋白(UMOD)在糖尿病肾病(DKD)肾小管损伤中的保护机制及临床转化价值。通过构建尿调蛋白基因敲除(UMOD-/-)大鼠模型,分别建立1型及2型糖尿病肾病模型,发现UMOD-/-糖尿病大鼠在两种模型中均表现出更明显的肾小管损伤,首次证实UMOD在DKD早期肾损伤中具有关键保护作用。机制研究发现,UMOD通过多通路发挥肾脏保护功能:1)转录组学分析显示UMOD-/-糖尿病大鼠肾脏补体通路活化显著增强,体外实验证实UMOD功能域重组片段(UMOD-FLR1)可有效抑制补体系统活化;2)分子相互作用研究表明UMOD及其EGF功能域(U-EGF)能够与表皮生长因子受体(EGFR)结合,抑制其下游信号通路异常激活;3)代谢检测分析发现UMOD-/-糖尿病大鼠血清甘油三酯及总胆固醇在糖尿病早期即显著升高,结合转录组富集分析结果,首次揭示UMOD通过调控AMPK-PPAR信号通路参与脂肪酸代谢调节。在转化医学研究方面,细胞实验证实外源性UMOD及其功能片段对肾小管上皮细胞损伤具有保护效应,初步探讨了UMOD蛋白替代治疗的可行性。本研究的创新性在于:首次阐明UMOD通过补体调节、EGFR信号抑制及脂代谢调控三重机制发挥肾脏保护作用;发现UMOD功能域片段具有独立生物学活性,为开发基于UMOD结构域的新型治疗策略奠定理论基础;揭示UMOD在糖脂代谢调控中的新功能,拓展了对DKD代谢紊乱机制的认识。这些发现不仅为深入理解DKD发病机制提供了新视角,更为基于UMOD及其功能片段的精准治疗策略开发提供了重要实验依据,具有显著的临床转化潜力。
尿调蛋白和补体H因子相互作用机制研究
-
批准号:81570664
-
项目类别:面上项目
-
资助金额:68.0万元
-
批准年份:2015
-
负责人:陈育青
-
依托单位:
尿调蛋白影响慢性肾脏病进展的机制研究
-
批准号:81270820
-
项目类别:面上项目
-
资助金额:70.0万元
-
批准年份:2012
-
负责人:陈育青
-
依托单位:
钙激活的大电流钾离子通道β1亚基影响慢性肾脏病进展的机制探讨
-
批准号:81070587
-
项目类别:面上项目
-
资助金额:38.0万元
-
批准年份:2010
-
负责人:陈育青
-
依托单位:
KCNMB1(钙激活的大电流钾离子通道β1亚基)与肾小球高滤过状态及慢性肾脏病进展相关
-
批准号:30940036
-
项目类别:专项基金项目
-
资助金额:10.0万元
-
批准年份:2009
-
负责人:陈育青
-
依托单位:
国内基金
海外基金